GENERIS Farmacêutica S.A. was acquired by Aurobindo Pharma on January 9, 2017

Life Science Company

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Join Mergr to view all 231 acquisitions of life science companies in 2017, including 16 acquisitions by private equity firms, and 215 by strategics.

GENERIS Farmacêutica, S.A.

Rua João de Deus, nº 19 - Venda Nova,
Amadora, 2700-487
Portugal,
351 21 924 8210
www.generis.pt

GENERIS® Farmacêutica, S.A. is a drug development, contract manufacturing and licensing-out company specialized in the manufacturing of solid oral dosage forms.


 Subscribe to unlock this and 163,914
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 152K M&A Transactions
  • 160K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 49K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.